New drug AZD0305 tested in multiple myeloma patients
NCT ID NCT06106945
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 22 times
Summary
This study tests a new drug called AZD0305, alone or with other cancer drugs, in about 226 adults with multiple myeloma. The goal is to check safety, find the right dose, and see if it helps control the cancer. Participants must have confirmed multiple myeloma and be in good enough health for the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGDuarte, California, 91010, United States
-
Research Site
RECRUITINGIrvine, California, 92618, United States
-
Research Site
RECRUITINGAtlanta, Georgia, 30322, United States
-
Research Site
RECRUITINGBoston, Massachusetts, 02215, United States
-
Research Site
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Research Site
RECRUITINGSt Louis, Missouri, 63110, United States
-
Research Site
RECRUITINGNew York, New York, 10065, United States
-
Research Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Research Site
RECRUITINGFairfax, Virginia, 22031, United States
-
Research Site
NOT_YET_RECRUITINGFitzroy, VIC3065, Australia
-
Research Site
RECRUITINGMelbourne, 3000, Australia
-
Research Site
RECRUITINGNedlands, 6009, Australia
-
Research Site
NOT_YET_RECRUITINGWollongong, 2500, Australia
-
Research Site
RECRUITINGHamilton, Ontario, L8V 5C2, Canada
-
Research Site
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
Research Site
NOT_YET_RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Research Site
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Research Site
NOT_YET_RECRUITINGNova Scotia, B3H 1V7, Canada
-
Research Site
RECRUITINGBeijing, 100044, China
-
Research Site
RECRUITINGChangsha, 410013, China
-
Research Site
RECRUITINGGuangzhou, 510060, China
-
Research Site
RECRUITINGShenyang, 110134, China
-
Research Site
RECRUITINGLille, 59037, France
-
Research Site
RECRUITINGNantes, 44000, France
-
Research Site
RECRUITINGEssen, 45147, Germany
-
Research Site
WITHDRAWNFreiburg im Breisgau, 79106, Germany
-
Research Site
RECRUITINGHamburg, 20246, Germany
-
Research Site
NOT_YET_RECRUITINGHeidelberg, 69120, Germany
-
Research Site
RECRUITINGLübeck, 23538, Germany
-
Research Site
RECRUITINGNuremberg, 90419, Germany
-
Research Site
NOT_YET_RECRUITINGTübingen, 72076, Germany
-
Research Site
RECRUITINGWürzburg, 97080, Germany
-
Research Site
RECRUITINGKashiwa, 277-8577, Japan
-
Research Site
RECRUITINGNagoya, 467-8602, Japan
-
Research Site
RECRUITINGYamagata, 990-9585, Japan
-
Research Site
NOT_YET_RECRUITINGBadalona, 8916, Spain
-
Research Site
RECRUITINGMadrid, 28027, Spain
-
Research Site
RECRUITINGMadrid, 28041, Spain
-
Research Site
RECRUITINGPamplona, 31005, Spain
-
Research Site
RECRUITINGSalamanca, 37007, Spain
Conditions
Explore the condition pages connected to this study.